LRG1 and non-small cell lung carcinoma: Clark et al. [59], Jakobsen et al. [60], and Li et al. [61] reported exosomal CD317, EGFR, and human leucine-rich alpha-2-glycoprotein 1 (LRG1) as potential biomarkers of non-small-cell lung cancer.